Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Efficacy and safety of aprepitant in japanese patients receiving high-dose chemotherapy followed by allogeneic hematopoietic stem cell transplantation

  • At: 2014 FIP Congress in Bangkok (Thailand)
  • Type: Poster
  • By: IKESUE, Hiroaki (Kyushu University Hospital, Department of Pharmacy, Fukuoka, Japan)
  • Co-author(s): Uchida, Mayako (Kyushu University Hospital, Fukuoka, Japan)
    Suetsugu, Kimitaka (Kyushu University Hospital, Fukuoka, Japan)
    Nagata, Kenichiro (Kyushu University Hospital, Fukuoka, Japan)
    Egashira, Nobuaki (Kyushu University Hospital, Fukuoka, Japan)
    Masuda, Satohiro (Kyushu University Hospital, Fukuoka, Japan)
  • Abstract:

    Background: Aprepitant, a neurokinin-1 receptor antagonist, has been shown to be effective for chemotherapy-induced nausea and vomiting. However, the usefulness of aprepitant in patients receiving high-dose chemotherapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) still remains unclear.
    Methods: We retrospectively..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses